Age and inflammation predict response to therapy in MS
Posted: Fri Oct 15, 2010 2:36 am
Patients who develop relapsing-remitting multiple sclerosis later in life and who have less inflammation are more likely to respond to immunomodulating therapies, report researchers.
Presenting here at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, investigators described demographic, clinical, and imaging predictors of response to first-line therapies....Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1763